These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25175122)

  • 1. Long-term survival of Japanese patients with pulmonary arterial hypertension treated with beraprost sodium, an oral prostacyclin analogue.
    Sakao S; Tanabe N; Kasahara Y; Tatsumi K
    Intern Med; 2014; 53(17):1913-20. PubMed ID: 25175122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
    Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
    Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beraprost therapy for pulmonary arterial hypertension.
    Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
    J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
    Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
    J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
    Tapson VF; Jing ZC; Xu KF; Pan L; Feldman J; Kiely DG; Kotlyar E; McSwain CS; Laliberte K; Arneson C; Rubin LJ;
    Chest; 2013 Sep; 144(3):952-958. PubMed ID: 23669822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of Japanese patients with pulmonary arterial hypertension after the introduction of endothelin receptor antagonists and/or phosphodiesterase type-5 inhibitors.
    Sakao S; Tanabe N; Kasahara Y; Tatsumi K
    Intern Med; 2012; 51(19):2721-6. PubMed ID: 23037462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
    Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
    J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of long-term therapy with oral Beraprost on survival of patients with arterial and inoperable thromboembolic pulmonary hypertension].
    Kurzyna M; Florczyk M; Fijałkowska A; Kuca P; Szewczyk G; Burakowski J; Kober J; Sikora J; Wawrzyńska L; Szturmowicz M; Tomkowskil W; Torbicki A
    Pol Arch Med Wewn; 2004 Apr; 111(4):477-82. PubMed ID: 15517762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension.
    Kunieda T; Nakanishi N; Matsubara H; Ohe T; Okano Y; Kondo H; Nishimura M; Shirato K; Tanabe N; Homma S; Yoshida S; Inokuma S; Kodama M; Koike T; Hishida H
    Int Heart J; 2009 Jul; 50(4):513-29. PubMed ID: 19609055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.
    Lang I; Gomez-Sanchez M; Kneussl M; Naeije R; Escribano P; Skoro-Sajer N; Vachiery JL
    Chest; 2006 Jun; 129(6):1636-43. PubMed ID: 16778286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.
    Vizza CD; Sciomer S; Morelli S; Lavalle C; Di Marzio P; Padovani D; Badagliacca R; Vestri AR; Naeije R; Fedele F
    Heart; 2001 Dec; 86(6):661-5. PubMed ID: 11711462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
    Melian EB; Goa KL
    Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Frequency of Acute Adverse Cardiovascular Events After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Receiving Preoperative Long-Term Intravenous Prostacyclin.
    Akagi S; Oto T; Kobayashi M; Miyoshi K; Sugimoto S; Yamane M; Nakamura K; Sarashina T; Miyoshi S; Ito H
    Int Heart J; 2017 Aug; 58(4):557-561. PubMed ID: 28690295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
    Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
    Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.
    Ikeda D; Tsujino I; Sakaue S; Ohira H; Itoh N; Kamigaki M; Ishimaru S; Atsumi T; Nishimura M
    Circ J; 2007 Nov; 71(11):1829-31. PubMed ID: 17965512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
    Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
    Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction.
    Ono F; Nagaya N; Okumura H; Shimizu Y; Kyotani S; Nakanishi N; Miyatake K
    Chest; 2003 May; 123(5):1583-8. PubMed ID: 12740277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.